Definition and epidemiology
Trichotillomania (TTM) is a chronic psychiatric condition defined by recurrent pulling out of one's hair, resulting in hair loss, along with repeated attempts to decrease or stop the behavior. It belongs to the DSM-5 category of obsessive-compulsive and related disorders, alongside excoriation (skin-picking) disorder and body dysmorphic disorder.
- Lifetime prevalence is estimated around 0.5-2% of the general population.
- Female-to-male ratio is approximately 10:1 in clinical samples, though this gap narrows in prepubertal children.
- Onset typically occurs in late childhood to early adolescence, often around puberty (peak onset 10-13 years).
- Often chronic and underreported due to shame and secrecy; many patients do not disclose symptoms unless specifically asked.
TTM frequently co-occurs with anxiety disorders, depression, and other body-focused repetitive behaviors such as skin picking or nail biting.
- TTM is classified as an obsessive-compulsive and related disorder in DSM-5, not a dermatologic disease.
- Classic exam buzzword: irregular, patchy alopecia with hairs of varying lengths — contrast with the smooth patches of alopecia areata.
- "Friar tonsure" pattern: hair loss on the crown/vertex, the area most reachable by the dominant hand, sparing the occipital and temporal margins.
- Biopsy shows trichomalacia, pigment casts, and increased catagen hairs without significant inflammation.
- Trichophagia (hair-eating) can rarely cause a gastric trichobezoar — "Rapunzel syndrome."
- First-line treatment is habit reversal training (a CBT technique), not medication.
- N-acetylcysteine and clomipramine have the best (though still modest) pharmacologic evidence; SSRIs are less consistently effective.
- Female-to-male ratio is roughly 10:1 in clinical populations, with onset typically in late childhood/adolescence.
Etiology and risk factors
The exact cause is unknown and is considered multifactorial, involving genetic, neurobiological, and psychological contributors.
- Genetic factors: Higher concordance in twins and increased risk with a first-degree relative who has TTM or OCD-spectrum disorders; mutations in the SLITRK1 gene have been studied but are not diagnostic.
- Neurobiological factors: Dysregulation of cortico-striato-thalamo-cortical circuits, similar to OCD; abnormalities in glutamatergic and serotonergic signaling have been proposed.
- Psychological factors: Hair pulling often serves as a maladaptive coping mechanism for stress, anxiety, boredom, or tension, and can also occur automatically (outside conscious awareness) or in a focused, intentional manner.
- Risk factors: Female sex, family history of TTM or OCD, co-existing anxiety or mood disorders, and history of trauma or significant stressors.
There is no single identified environmental trigger, and the disorder is not caused by a dermatologic disease, though stress commonly exacerbates it.
Pathophysiology
Repetitive mechanical traction on hair follicles from pulling leads to characteristic histologic and clinical changes, but the underlying driver is behavioral/neuropsychiatric rather than dermatologic.
- Pulling is thought to activate a tension-reduction cycle: rising tension or urge, the pulling act itself, and subsequent relief or gratification, which reinforces the behavior (similar to habit/addiction-like circuitry).
- Two clinical subtypes are described: automatic pulling (occurs outside full awareness, e.g., while reading or watching TV) and focused pulling (deliberate, often to relieve a specific sensory or emotional urge).
- Histologically, affected follicles show trichomalacia (irregular, distorted follicles), increased catagen (telogen) hairs, pigment casts in the follicular canal, and absence of significant perifollicular inflammation — this helps distinguish TTM from alopecia areata or scarring alopecia.
- Chronic pulling can eventually damage the follicle enough to reduce regrowth, though scarring alopecia is uncommon.
Clinical features
Patients present with patchy, irregular hair loss, most commonly from the scalp, but eyebrows, eyelashes, and pubic hair can also be affected.
- Hair loss is typically asymmetric and irregular, with hairs of varying lengths within the affected area (unlike the uniform shedding of alopecia areata).
- A classic finding is the "friar tonsure" pattern — hair loss affecting the crown/vertex, the area most accessible to the dominant hand, while sparing the occipital and temporal margins (mirroring the tonsure hairstyle of monks).
- Patients often report an increasing sense of tension before pulling and relief, gratification, or pleasure afterward.
- Many patients engage in associated behaviors: examining, playing with, or trichophagia (eating the pulled hair), which can rarely lead to a gastric trichobezoar (Rapunzel syndrome).
- Behavior is frequently done in private; patients often minimize or deny pulling to family or clinicians due to embarrassment.
- Associated psychological distress, social avoidance (e.g., wearing wigs, scarves, avoiding swimming), and comorbid anxiety or depressive symptoms are common.
Diagnosis
Diagnosis is primarily clinical, based on history and physical examination; it is a diagnosis of exclusion once dermatologic causes are ruled out.
DSM-5 diagnostic criteria
- Recurrent pulling out of one's hair, resulting in hair loss.
- Repeated attempts to decrease or stop hair pulling.
- The hair pulling causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
- The hair pulling or hair loss is not attributable to another medical condition (e.g., a dermatologic condition).
- The hair pulling is not better explained by another mental disorder (e.g., attempts to improve a perceived defect in appearance in body dysmorphic disorder).
Workup
- Careful history, often requiring direct, non-judgmental questioning since patients may not volunteer the behavior.
- Dermoscopy (trichoscopy) can show short, broken hairs of varying length, coiled hairs, and "V-sign" (two hairs emerging from one follicle and broken at the same length).
- Scalp biopsy is reserved for unclear cases and shows trichomalacia, increased catagen hairs, and pigment casts without significant inflammation.
- Screen for comorbid psychiatric conditions (anxiety, depression, OCD, other body-focused repetitive behaviors).
Differential diagnosis
| Condition | Distinguishing feature |
|---|---|
| Alopecia areata | Smooth, well-circumscribed patches; "exclamation point" hairs; no behavioral component |
| Tinea capitis | Scaling, pruritus, broken hairs at scalp surface, positive fungal culture/KOH |
| Traction alopecia | History of tight hairstyles/braids; hair loss along hairline/part lines |
| Telogen effluvium | Diffuse shedding, often post-stressor/illness, no patchy pulling behavior |
| Body dysmorphic disorder | Hair removal is to "fix" a perceived appearance flaw, not tension-driven |
| Excoriation (skin-picking) disorder | Picking skin rather than hair; may co-occur with TTM |
Key distinguishing point: in TTM there is no primary dermatologic inflammation, and the irregular pattern plus patient's own repetitive behavior (often denied initially) are the clues.
Management
Treatment is primarily behavioral; evidence for medications is weaker and more mixed, so psychotherapy is favored as first-line across major guidelines.
First-line
- Habit reversal training (HRT), a form of cognitive-behavioral therapy, is the most well-supported treatment. It involves awareness training, identifying triggers, and substituting a competing response (e.g., clenching fists) when the urge to pull arises.
- Acceptance and commitment therapy (ACT) and dialectical behavior therapy (DBT)-based skills (emotion regulation) are also used, often combined with HRT in a comprehensive behavioral model.
Pharmacotherapy
- No medication is FDA-approved specifically for TTM.
- N-acetylcysteine (NAC) has shown modest benefit in some trials, particularly in adults, via modulation of glutamatergic pathways.
- SSRIs are commonly tried, especially when depression or anxiety coexists, though evidence specifically for TTM symptom reduction is limited and mixed.
- Clomipramine (a tricyclic with serotonergic activity) has some supporting evidence, more so than SSRIs in several trials.
- Olanzapine and other atypical antipsychotics have been used adjunctively in refractory cases, though data is limited.
General approach
- Address comorbid psychiatric conditions.
- Education and reassurance for patients and families; involve family therapy in children/adolescents.
- Dermatologic referral if secondary skin changes or diagnostic uncertainty exists.
- Psychiatric referral for treatment-resistant or severe cases, or when trichophagia/trichobezoar risk is present (consider abdominal imaging if trichophagia is suspected).
Complications and prognosis
Course is variable; some children have mild, self-limited episodes while adults often have a chronic, waxing-and-waning course.
- Permanent hair loss/scarring can occur with long-standing, severe pulling, though it is uncommon.
- Trichobezoar (Rapunzel syndrome): a rare but serious complication of trichophagia, where ingested hair accumulates in the stomach, potentially causing obstruction, pain, or perforation and requiring surgical removal.
- Secondary skin infection or folliculitis at pulling sites.
- Significant psychosocial impact: low self-esteem, social withdrawal, avoidance of activities (swimming, wind, intimate relationships), and impaired academic/occupational functioning.
- Prognosis is generally better with early identification and treatment, particularly in children, where spontaneous remission is more common than in adults with chronic disease.
PULL: Patchy irregular hair loss, Urge-tension-relief cycle, Loss of eyebrows/lashes too, Likely co-occurring anxiety/OCD
Practice questions
1. A 12-year-old girl is brought in by her mother due to patchy hair loss over the past 4 months. On exam, there are irregular areas of alopecia on the scalp with hairs of varying length; the scalp skin appears normal with no scaling or erythema. The patient admits to pulling her hair when stressed about schoolwork, stating she feels tense beforehand and relieved afterward. Which of the following best supports the diagnosis of trichotillomania over alopecia areata?
2. A 16-year-old boy with known trichotillomania and a habit of trichophagia presents with recurrent abdominal pain, early satiety, and a palpable, mobile epigastric mass. Which complication should be most strongly suspected?
3. A 24-year-old woman with trichotillomania has not responded adequately to habit reversal training alone. She and her psychiatrist are considering adjunctive pharmacotherapy. Which of the following medications has the most supporting evidence specifically for reducing hair-pulling behavior, among the choices listed?
Frequently asked questions
What causes trichotillomania?
Trichotillomania does not have one single cause; it results from a combination of genetic predisposition, dysregulation of brain circuits involved in impulse control (similar to those seen in OCD), and psychological factors like using hair pulling to relieve stress, anxiety, or boredom. Family history of trichotillomania or OCD-spectrum disorders increases risk. It is not caused by a skin disease, nutritional deficiency, or external toxin.
What are the first symptoms of trichotillomania?
Early symptoms usually include a rising sense of tension or urge before pulling hair, followed by relief or satisfaction after pulling, often from the scalp, eyebrows, or eyelashes. Family or patients may first notice thinning patches with hairs of uneven length rather than smooth bald spots. Onset is most common around puberty, typically between ages 10 and 13.
How is trichotillomania diagnosed?
Diagnosis is clinical, based on DSM-5 criteria: recurrent hair pulling causing hair loss, repeated attempts to stop, and significant distress or impairment, after ruling out dermatologic causes like alopecia areata or tinea capitis. Dermoscopy can support the diagnosis by showing broken hairs of varying length and characteristic "V-sign" patterns. Biopsy is rarely needed but can confirm the diagnosis in ambiguous cases.
Is trichotillomania curable?
Trichotillomania is not always "cured" in a permanent sense, but it is very manageable, and many people, especially children, achieve long-term remission with treatment. Habit reversal training, a structured behavioral therapy, is the most effective approach and can substantially reduce or stop pulling. Chronic cases in adults may need ongoing management, similar to other OCD-spectrum conditions.
Trichotillomania vs alopecia areata — what is the difference?
Trichotillomania causes irregular, patchy hair loss with hairs of different lengths due to a behavioral pulling disorder, while alopecia areata causes smooth, well-defined bald patches from an autoimmune attack on hair follicles, unrelated to behavior. Alopecia areata often shows "exclamation point" hairs on exam, while trichotillomania shows trichomalacia and pigment casts on biopsy. Alopecia areata is not accompanied by an urge-tension-relief cycle.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F63.3
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.